Please visit answersincme.com/BZG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses new evidence for targeting PD-1/PD-L1 inhibition in locally advanced cervical cancer. Upon completion of this activity, participants should be better able to: Recognize the rationale for therapeutically targeting the PD-1/PD-L1 axis to address unmet treatment needs in locally advanced cervical cancer; Describe ongoing studies and preliminary evidence for late-stage emerging PD-1/PD-L1 inhibitors being investigated for the treatment of locally advanced cervical cancer; and Outline current and potential future roles of PD-1/PD-L1 inhibitors in cervical cancer management.